⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BEAM News
Beam Therapeutics Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
prnewswire.com
BEAM
Global Cell & Gene Therapy Market Size and Forecast Report 2026-2036 | Market to Reach US$126.86 Billion at 17.3% CAGR as CRISPR, CAR-T and Scalable Manufacturing Drive Growth
globenewswire.com
ALLO
ATRA
BEAM
BMRN
BMY
CRSP
GILD
INTC
JNJ
NVS
VRTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
globenewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
accessnewswire.com
BEAM